Boehringer Ingelheim is one of the world's leading research-driven pharmaceutical companies with 130 years of experience. Click here for a media overview.
We are proud to play a critical role in feeding the world with safe, affordable, abundant and sustainable quality poultry meat and eggs. Learn more here.
Click here to download Boehringer Ingelheim's 2025 Manifesto detailing the long term initiative to improve health around the world for all communities.
Click here to read the terms of use on which you may make use of the website www.boehringer-ingelheim.com/in, whether as a visitor or a registered user.
Boehringer Ingelheim is dedicated to the discovery, development, manufacture and marketing of innovative health care products. Click here to learn more.
Boehringer Ingelheim developed the only licensed blood clot dissolving treatment (thrombolytic) for acute ischaemic stroke therapy, now used worldwide.
Boehringer Ingelheim objectives and beliefs can be summed up in a single phrase: value through Innovation, the central concept of our corporate vision.